Hyung Suk Kim1, Ja Hyeon Ku1, Chang Wook Jeong1, Cheol Kwak1, Hyeon Hoe Kim2,3. 1. Department of Urology, Seoul National University College of Medicine, Seoul, Korea. 2. Department of Urology, Seoul National University College of Medicine, Seoul, Korea. hhkim@snu.ac.kr. 3. Department of Urology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Korea. hhkim@snu.ac.kr.
Abstract
PURPOSE: To compare survival outcomes between laparoscopic radical nephroureterectomy (LRNU) and open radical nephroureterectomy (ORNU) in upper urinary tract urothelial carcinoma (UTUC) patients. METHODS: We retrospectively analyzed the data of 371 UTUC patients who underwent ORNU (n = 271) or LRNU (n = 100) between 1992 and 2012. The survival outcomes included intravesical recurrence (IVR)-free survival, overall survival (OS), and cancer-specific survival (CSS). The Kaplan-Meier method and log-rank test were used to estimate and compare survival curves between groups. Factors associated with survival outcomes were evaluated using univariable and multivariable Cox proportional hazard models. RESULTS: The three-year IVR-free survival rates were similar between the ORNU and LRNU groups (59.9 and 61.7 %, p = 0.267). However, the LRNU group showed worse five-year OS (59.1 vs. 75.2 %, p = 0.027) and CSS (66.1 vs. 80.2 %, p = 0.015) rates than the ORNU group. In particular, on stratifying the study cohort by pathological stages, significant differences in OS (p = 0.007) and CSS (p = 0.005) between the surgical approaches were observed only in locally advanced disease (pT3/T4). In multivariable analysis, LRNU was an independent predictor of worse OS (p = 0.001) and CSS (p = 0.006) than ORNU. Likewise, in multivariable analysis in patients with pT3/T4 stage, LRNU was significantly associated with worse OS (hazard ratio [HR] 2.59, p = 0.001) and CSS (HR 2.50, p = 0.005). CONCLUSIONS: Our data suggest that in UTUC patients, LRNU, compared to ORNU, is generally associated with unfavorable OS and CSS results. In particular, LRNU should be performed in locally advanced UTUC patients after careful consideration of its impact on patient survival.
PURPOSE: To compare survival outcomes between laparoscopic radical nephroureterectomy (LRNU) and open radical nephroureterectomy (ORNU) in upper urinary tract urothelial carcinoma (UTUC) patients. METHODS: We retrospectively analyzed the data of 371 UTUC patients who underwent ORNU (n = 271) or LRNU (n = 100) between 1992 and 2012. The survival outcomes included intravesical recurrence (IVR)-free survival, overall survival (OS), and cancer-specific survival (CSS). The Kaplan-Meier method and log-rank test were used to estimate and compare survival curves between groups. Factors associated with survival outcomes were evaluated using univariable and multivariable Cox proportional hazard models. RESULTS: The three-year IVR-free survival rates were similar between the ORNU and LRNU groups (59.9 and 61.7 %, p = 0.267). However, the LRNU group showed worse five-year OS (59.1 vs. 75.2 %, p = 0.027) and CSS (66.1 vs. 80.2 %, p = 0.015) rates than the ORNU group. In particular, on stratifying the study cohort by pathological stages, significant differences in OS (p = 0.007) and CSS (p = 0.005) between the surgical approaches were observed only in locally advanced disease (pT3/T4). In multivariable analysis, LRNU was an independent predictor of worse OS (p = 0.001) and CSS (p = 0.006) than ORNU. Likewise, in multivariable analysis in patients with pT3/T4 stage, LRNU was significantly associated with worse OS (hazard ratio [HR] 2.59, p = 0.001) and CSS (HR 2.50, p = 0.005). CONCLUSIONS: Our data suggest that in UTUC patients, LRNU, compared to ORNU, is generally associated with unfavorable OS and CSS results. In particular, LRNU should be performed in locally advanced UTUC patients after careful consideration of its impact on patient survival.
Authors: Thomas J Walton; Giacomo Novara; Kazumasa Matsumoto; Wassim Kassouf; Hans-Martin Fritsche; Walter Artibani; Patrick J Bastian; Juan I Martínez-Salamanca; Christian Seitz; Stephen A Thomas; Vincenzo Ficarra; Maximilian Burger; Stefan Tritschler; Pierre I Karakiewicz; Shahrokh F Shariat Journal: BJU Int Date: 2010-11-15 Impact factor: 5.588
Authors: Nawar Hanna; Maxine Sun; Quoc-Dien Trinh; Jens Hansen; Marco Bianchi; Francesco Montorsi; Shahrokh F Shariat; Markus Graefen; Paul Perrotte; Pierre I Karakiewicz Journal: Eur Urol Date: 2011-12-22 Impact factor: 20.096
Authors: Morgan Rouprêt; Marko Babjuk; Eva Compérat; Richard Zigeuner; Richard Sylvester; Max Burger; Nigel Cowan; Andreas Böhle; Bas W G Van Rhijn; Eero Kaasinen; Joan Palou; Shahrokh F Shariat Journal: Eur Urol Date: 2013-03-19 Impact factor: 20.096
Authors: Umberto Capitanio; Shahrokh F Shariat; Hendrik Isbarn; Alon Weizer; Mesut Remzi; Marco Roscigno; Eiji Kikuchi; Jay D Raman; Christian Bolenz; Karim Bensalah; Theresa M Koppie; Wassim Kassouf; Mario I Fernández; Philipp Ströbel; Jeffrey Wheat; Richard Zigeuner; Cord Langner; Matthias Waldert; Mototsugu Oya; Charles C Guo; Casey Ng; Francesco Montorsi; Christopher G Wood; Vitaly Margulis; Pierre I Karakiewicz Journal: Eur Urol Date: 2009-04-03 Impact factor: 20.096
Authors: Morgan Rouprêt; Vincent Hupertan; Kristin M Sanderson; Justin D Harmon; Xavier Cathelineau; Eric Barret; Guy Vallancien; François Rozet Journal: Urology Date: 2007-04 Impact factor: 2.649
Authors: Matthias Waldert; Mesut Remzi; Hans Christoph Klingler; Lukas Mueller; Michael Marberger Journal: BJU Int Date: 2008-08-14 Impact factor: 5.588
Authors: Marco Moschini; Beat Foerster; Mohammad Abufaraj; Francesco Soria; Thomas Seisen; Morgan Roupret; Pierre Colin; Alexandre De la Taille; Benoit Peyronnet; Karim Bensalah; Roman Herout; Manfred Peter Wirth; Vladimir Novotny; Piotr Chlosta; Marco Bandini; Francesco Montorsi; Giuseppe Simone; Michele Gallucci; Giuseppe Romeo; Kazumasa Matsumoto; Pierre Karakiewicz; Alberto Briganti; Shahrokh F Shariat Journal: World J Urol Date: 2017-02-28 Impact factor: 4.226